{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:35:19Z","timestamp":1789122919904,"version":"build-2803163510"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>For nonmetastatic locally advanced gallbladder cancer (LAGBC) which remains unresectable and nonmetastatic after chemotherapy, there is no consensus on whether to continue chemotherapy or add local radiotherapy (RT) for improving outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Forty-five patients of surgically unresectable nonmetastatic LAGBC were analyzed. Twenty patients did not receive RT (no RT cohort) and received only chemotherapy, while 25 patients received RT (RT cohort) with conformal techniques along with concurrent gemcitabine-based chemotherapy. No RT and RT cohorts were compared for disease-related outcomes and toxicities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Median follow-up of the entire cohort was 11.5 months. Two-year progression-free survival (18.6% vs. 0%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001) and overall survival (37.3% vs. 5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001) were significantly better in the RT cohort as compared to a no RT cohort. More number of patients had locoregional progression in the no RT cohort (85% vs. 32%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0002). Radiation-induced acute and late gastrointestinal toxicity \u2265 RTOG Grade 3 were seen in one and two patients, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Addition of local RT to chemotherapy improves the survival outcomes and can be considered as a definite treatment modality for nonmetastatic LAGBC patients not amenable to surgery who have responded to chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1568_20","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T10:31:54Z","timestamp":1674815514000},"page":"147-151","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Radiotherapy for locally advanced unresectable gallbladder cancer - A way forward: Comparative study of chemotherapy versus chemoradiotherapy"],"prefix":"10.4103","volume":"18","author":[{"given":"Shwetabh","family":"Sinha","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Engineer","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Ostwal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Ramaswamy","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Chopra","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"R3-20250510","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/j.hpb.2016.02.127","article-title":"Outcomes following surgical resection of 515 patients with gall bladder cancer: Indian experience","volume":"18","author":"Goel","year":"2016","journal-title":"HPB"},{"key":"R4-20250510","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s005340100019","article-title":"Irradiation therapy for gallbladder carcinoma: Recent advances","volume":"8","author":"Houry","year":"2001","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R5-20250510","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/1097-0142(19910715)68:2<289::AID-CNCR2820680213>3.0.CO;2-2","article-title":"Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases","volume":"68","author":"Flickinger","year":"1991","journal-title":"Cancer"},{"key":"R6-20250510","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ijrobp.2006.05.061","article-title":"External-beam radiotherapy for localized extrahepatic cholangiocarcinoma","volume":"66","author":"Ben-David","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20250510","doi-asserted-by":"crossref","first-page":"59","DOI":"10.6004\/jnccn.2017.7067","article-title":"Chemoradiotherapy versus chemotherapy alone for unresected nonmetastatic gallbladder cancer: National practice patterns and outcomes","volume":"16","author":"Verma","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"R8-20250510","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/cam4.975","article-title":"Does radiotherapy still have a role in unresected biliary tract cancer?","volume":"6","author":"Pollom","year":"2017","journal-title":"Cancer Med"},{"key":"R9-20250510","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2217\/fon.14.308","article-title":"Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer","volume":"11","author":"Sirohi","year":"2015","journal-title":"Future Oncol"},{"key":"R10-20250510","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1245\/s10434-016-5197-0","article-title":"Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Gallbladder Cancers: A New Paradigm","volume":"23","author":"Engineer","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R11-20250510","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.hpb.2018.03.008","article-title":"Outcome of neoadjuvant chemotherapy in \u201clocally advanced\/borderline resectable\u201d gallbladder cancer: the need to define indications","volume":"20","author":"Chaudhari","year":"2018","journal-title":"HPB"},{"key":"R12-20250510","first-page":"132","article-title":"RECIST 1.1 \u2013 Update and Clarification: From the RECIST Committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"R17-20250510","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ejso.2013.10.014","article-title":"Locally advanced gallbladder cancer: Which patients benefit from resection?","volume":"40","author":"Birnbaum","year":"2014","journal-title":"Eur J Surg Oncol EJSO"},{"key":"R18-20250510","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21037\/cco.2019.08.12","article-title":"Contemporary perspectives on the use of radiation therapy for locally advanced gallbladder cancer","volume":"8","author":"Verma","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"R19-20250510","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.clon.2019.08.003","article-title":"A Retrospective Study of the Dosimetric Parameters and Duodenal Toxicity in Patients With Upper Gastrointestinal and Gynaecological Cancers Treated With Radiation Therapy","volume":"32","author":"George","year":"2020","journal-title":"Clinical Oncology"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1568_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:12Z","timestamp":1787067492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1568_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1568_20","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2020-10-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}